In patients with MI/PAD and no prior stroke or transient ischemic attack , vorapaxar reduced first ischemic stroke ( hazard ratio -LSB- HR -RSB- : @ , @ % confidence interval -LSB- CI -RSB- : @ to @ ; p < @ ) .